Corteva annual shareholders’ equity
2018
2019
2020
2021
2022
2023
2024
2025
Corteva Shareholders’ Equity Growth & History (CTVA)
Corteva's shareholders’ equity was $24.14B for fiscal 2025.
View full Corteva company overviewCorteva annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24.14B | $355.0M | +1.49% |
| 2024 | 2024-12-31 | $23.79B | −$1.25B | −4.98% |
| 2023 | 2023-12-31 | $25.04B | −$265.0M | −1.05% |
| 2022 | 2022-12-31 | $25.30B | −$82.0M | −0.32% |
| 2021 | 2021-12-31 | $25.38B | $560.0M | +2.26% |
| 2020 | 2020-12-31 | $24.82B | $515.0M | +2.12% |
| 2019 | 2019-12-31 | $24.31B | −$50.35B | −67.44% |
| 2018 | 2018-12-31 | $74.66B | — | — |
Corteva quarterly shareholders’ equity
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $25.16B | −$750.0M | −2.89% |
| Q1 2026 | 2026-03-31 | $24.36B | $77.0M | +0.32% |
| Q4 2025 | 2025-12-31 | $24.14B | $355.0M | +1.49% |
| Q3 2025 | 2025-09-30 | $25.22B | $482.0M | +1.95% |
| Q2 2025 | 2025-06-30 | $25.91B | $730.0M | +2.90% |
| Q1 2025 | 2025-03-31 | $24.29B | −$482.0M | −1.95% |
| Q4 2024 | 2024-12-31 | $23.79B | −$1.25B | −4.98% |
| Q3 2024 | 2024-09-30 | $24.74B | −$489.0M | −1.94% |
| Q2 2024 | 2024-06-30 | $25.18B | −$1.04B | −3.97% |
| Q1 2024 | 2024-03-31 | $24.77B | −$832.0M | −3.25% |
| Q4 2023 | 2023-12-31 | $25.04B | −$265.0M | −1.05% |
| Q3 2023 | 2023-09-30 | $25.23B | $382.0M | +1.54% |
| Q2 2023 | 2023-06-30 | $26.22B | $389.0M | +1.51% |
| Q1 2023 | 2023-03-31 | $25.60B | −$97.0M | −0.38% |
| Q4 2022 | 2022-12-31 | $25.30B | −$82.0M | −0.32% |
| Q3 2022 | 2022-09-30 | $24.84B | $104.0M | +0.42% |
| Q2 2022 | 2022-06-30 | $25.83B | $446.0M | +1.76% |
| Q1 2022 | 2022-03-31 | $25.70B | $1.16B | +4.72% |
| Q4 2021 | 2021-12-31 | $25.38B | $560.0M | +2.26% |
| Q3 2021 | 2021-09-30 | $24.74B | $634.0M | +2.63% |
| Q2 2021 | 2021-06-30 | $25.39B | $824.0M | +3.35% |
| Q1 2021 | 2021-03-31 | $24.54B | $713.0M | +2.99% |
| Q4 2020 | 2020-12-31 | $24.82B | $515.0M | +2.12% |
| Q3 2020 | 2020-09-30 | $24.11B | −$909.0M | −3.63% |
| Q2 2020 | 2020-06-30 | $24.56B | −$1.25B | −4.84% |
| Q1 2020 | 2020-03-31 | $23.82B | −$50.75B | −68.05% |
| Q4 2019 | 2019-12-31 | $24.31B | −$50.35B | −67.44% |
| Q3 2019 | 2019-09-30 | $25.02B | — | — |
| Q2 2019 | 2019-06-30 | $25.81B | — | — |
| Q1 2019 | 2019-03-31 | $74.57B | — | — |
| Q4 2018 | 2018-12-31 | $74.66B | — | — |
Corteva shareholders’ equity trends
Over the last five fiscal years, Corteva's shareholders’ equity decreased from $24.82B to $24.14B, a change of −$680.0M. The latest reported quarter, Q2 2026, shows $25.16B.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Corteva source filings ↗Community posts
Corteva settles Inari seed-IP case, with licensing talks still pending
Corteva ($CTVA) and Inari have reached a confidential settlement of Corteva’s seed-related intellectual-property lawsuit in Delaware. Inari agreed to destroy Corteva material accessed through seed depositories, together with material develo ...
Corteva clears SEC registration milestone for Vylor separation
Corteva ($CTVA) said the SEC declared Vylor’s Form 10 registration statement effective, advancing the planned separation of its seed and genetics business. Eligible Corteva shareholders are scheduled to receive one Vylor share for each Cort ...
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...
